FindTrial
Sign In

THE EFFECTIVENESS OF SIDDHA FORMULATIONS SOMBU THEENEER AND PEENISATHIRKU THAILAM IN THE MANAGEMENT OF PEENISAM

AN OPEN NON RANDOMIZED CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF SIDDHA FORMULATIONS SOMBU THEENEER (INTERNAL) AND PEENISATHIRKU THAILAM (EXTERNAL) IN THE MANAGEMENT OF PEENISAM (SINUSITIS)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/02/040236
Enrollment
10
Registered
2022-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J019- Acute sinusitis, unspecified

Interventions

Intervention1: SOMBU THEENEER (INTERNAL) AND PEENISATHIRKU THAILAM (EXTERNAL): DOSAGE:30ml twice a day after food Adjuvant:warm water Duration of treatment: 48 days Control Intervention1: NOT APPLICAB

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age: 18-60 years Men and Women, Transgender. Patients who are willing to give informed consent. Headache, sneezing, nasal congestion,rhinorrhea,postnasaldrip,facial pain,anosmia. Pain and tenderness over paranasal sinuses. Patient who has radiological evidence of sinusitis. Patient who has Adelaide Disease Severity Score above 12

Exclusion criteria

Exclusion criteria: K/C/O Migraine Patients who are not willing to participate in the study will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
K/C/O Migraine Patients who are not willing to participate in the study will be excluded from the study.Timepoint: 49TH DAY—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr G DHIVYA

National Institute of Siddha Tambaram

dr.vetha@gmail.com9894782366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026